Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 423

Results For "IND"

6585 News Found

Ajooni Biotech awarded ZED certification by Ministry of MSME
Biotech | November 22, 2022

Ajooni Biotech awarded ZED certification by Ministry of MSME

The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration


Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets
Drug Approval | November 22, 2022

Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets

Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022


Lupin signs MoU with Govt. of Rajasthan to strengthen healthcare system
Healthcare | November 22, 2022

Lupin signs MoU with Govt. of Rajasthan to strengthen healthcare system

LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes


Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr
News | November 22, 2022

Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr

The proceeds from this fund-raise will be deployed in financing the project requirements of the API business


Merck to acquire Imago BioSciences for $1.35 bn
News | November 22, 2022

Merck to acquire Imago BioSciences for $1.35 bn

Acquisition expands Merck’s growing hematology portfolio


Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar
News | November 21, 2022

Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar

The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine


Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
Clinical Trials | November 21, 2022

Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster

Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data


Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures
News | November 21, 2022

Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures

The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.


Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection
Drug Approval | November 19, 2022

Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection

The product is expected to be launched by Q4 FY23.


Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
Healthcare | November 18, 2022

Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast

Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning